Prime Capital Investment Advisors, LLC Biogen Inc. Transaction History
Prime Capital Investment Advisors, LLC
- $6.71 Billion
- Q4 2024
A detailed history of Prime Capital Investment Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 3,274 shares of BIIB stock, worth $388,329. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,274
Previous 5,079
35.54%
Holding current value
$388,329
Previous $984,000
49.19%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding BIIB
# of Institutions
1,016Shares Held
127MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$1.99 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$1.9 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.72 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$878 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA3.7MShares$438 Million0.04% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $17.1B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...